FIL Ltd - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q2 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.

Quarter-by-quarter ownership
FIL Ltd ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q1 2023$4,824,900
-12.3%
45,000
-0.1%
0.01%
-14.3%
Q4 2022$5,503,788
+5043.7%
45,065
+6636.2%
0.01%
Q3 2021$107,000
-99.4%
669
-99.5%
0.00%
-100.0%
Q2 2021$17,760,000
-19.8%
134,994
-21.5%
0.02%
-24.0%
Q1 2021$22,151,000
-18.8%
171,883
+5.1%
0.02%
-26.5%
Q4 2020$27,273,000
+86.2%
163,524
+72.3%
0.03%
+88.9%
Q3 2020$14,647,000
+4.5%
94,917
+0.1%
0.02%
-5.3%
Q2 2020$14,020,000
-35.2%
94,793
-50.6%
0.02%
-47.2%
Q1 2020$21,645,000
-8.1%
191,964
+13.2%
0.04%
+9.1%
Q4 2019$23,556,000
+32.7%
169,636
-8.1%
0.03%
+22.2%
Q3 2019$17,747,000
-28.0%
184,603
-13.8%
0.03%
-27.0%
Q2 2019$24,663,000
-15.7%
214,178
-13.9%
0.04%
-19.6%
Q1 2019$29,271,000
+268.5%
248,699
+96.2%
0.05%
+228.6%
Q4 2018$7,943,000
-0.9%
126,787
+12.1%
0.01%
+16.7%
Q3 2018$8,016,000
+247.8%
113,118
+226.5%
0.01%
+300.0%
Q2 2018$2,305,00034,6440.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q2 2023
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders